CATALYST: The Industrialization of Advanced iPSC Technology for Drug Discovery & Development
Dan Shoemaker, Ph.D., CTO (Fate), Stephen Chang, Ph.D., CSO (Stemgent) will present a short talk describing CATALYST:
- Induced pluripotent stem cells (iPSCs) are considered to be of great potential for toxicity testing, disease research and primary drug screening.
- Catalyst is an alliance between Fate Therapeutics and Stemgent to translate groundbreaking induced pluripotent stem cell (iPSC) discoveries into cutting-edge iPSC technologies with standardized and optimized products and services for Catalyst Members to have exclusive access to a new paradigm in drug discovery and development.
- The alliance is a powerful aggregation of complementary expertise, foundational intellectual property and scientific founders and advisory board members.
- Catalyst Members will benefit from Fate’s expertise in stem cell biology research and the discovery and development of small molecules and biologics to modulate cell fate combined with Stemgent’s expertise in superior reagent design, production capabilities and customer support.
About Fate Therapeutics, Inc.
Fate Therapeutics is interrogating adult stem cell biology and applying induced pluripotent stem cell (iPSC) technology to develop Stem Cell Modulators (SCMs), small molecule or biologic compounds that guide cell fate for therapeutic purposes. Fate’s approach has broad therapeutic potential in areas such as regenerative medicine, hematological diseases, metastatic cancer, traumatic injury and degenerative diseases. In addition, Fate Therapeutics and Stemgent have formed an alliance – Catalyst – a collaborative program to provide Catalyst Members with first access to the most advanced iPSC technologies for drug discovery and development. Fate Therapeutics is headquartered in La Jolla, CA. For more information, please visit http://www.fatetherapeutics.com.
Stemgent helps our customers advance stem cell science by providing proprietary reagents and technologies developed by some of the world’s leading stem cell scientists. Stemgent’s product offering includes virus-delivered reprogramming factors for iPS cell generation, cytokines and matrices for healthy stem cell growth, primary and reporter cell lines, stem cell characterization tools, polymers for transfection, and small molecules for reprogramming, self-renewal and differentiation. This unique product mix is designed to serve researchers who study stem cell biology and regenerative medicine, and those who use cells derived from stem cells to advance their understanding of major diseases. For more information visit us at www.stemgent.com.
Who: Biotechnology professionals in the greater San Diego area
What: San Diego Biotechnology Network’s July Networking Event Featuring Fate Therapeutics and Stemgent
When: Tuesday, July 21st, 5:30-9:00 p.m.
Where: Tango Del Rey, 3567 Del Rey Street, San Diego 92109 (Directions below)
Cost: $20, including appetizers ($15 for Academics) +$5 at door
For more information about the event: http://sdbn.org/july
Directions: From the North: South on Interstate 5, Exit Balboa Ave, Straight to 4th Traffic Light then left on Bunker Hill St. Building directly ahead 3 blks. From the South: North on Interstate 5, Exit Grand/ Garnet Ave, Straight to 3rd Traffic Light then right on Bunker Hill St. Building directly ahead 3 blks.